Intended for healthcare professionals


National service framework's financial implications are huge

BMJ 2000; 321 doi: (Published 16 September 2000) Cite this as: BMJ 2000;321:705
  1. Anthony S Wierzbicki, senior lecturer in chemical pathology,
  2. Timothy M Reynolds, professor of chemical pathology
  1. St Thomas's Hospital, London SE1 7EH
  2. Queen's Hospital, Burton-on-Trent DE13 0RB

    EDITOR—We are delighted that tools for assessment of risk of cardiovascular disease have been addressed in a whole issue of the BMJ.1 It is unfortunate that so many calculators (Sheffield mark 2; New Zealand mark 2) cannot agree on definitions and may not in fact give the same results for each patient.2 We have compared 10 risk algorithms, and, while the Sheffield tables underestimate risk in patients with diabetes at 3% per year, the revised (but not the old) New Zealand guidelines match the performance of other guidelines: …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription